Memantine for the treatment of childhood behavioral disorders

Details for Australian Patent Application No. 2005286672 (hide)

Owner Merz Pharma GmbH & Co. KgaA

Inventors Mann, Allison; Banerjee, Pradeep K.; Moebius, Hans-Joerg; Jonas, Jeffrey; Gupta, Sandeep

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2005286672

PCT Pub. Number WO2006/034465

Priority 60/612,600 23.09.04 US

Filing date 23 September 2005

Wipo publication date 30 March 2006

Acceptance publication date 12 March 2009

International Classifications

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 25/22 (2006.01) Drugs for disorders of the nervous system

A61P 25/24 (2006.01) Drugs for disorders of the nervous system

Event Publications

19 April 2007 PCT application entered the National Phase

  PCT publication WO2006/034465 Priority application(s): WO2006/034465

12 March 2009 Application Accepted

  Published as AU-B-2005286672

9 July 2009 Standard Patent Sealed

21 April 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005286675-Materials handling vehicle having substantially all hydraulic components mounted on a main frame assembly

2005286666-Alkoxylated alkylamines / alkyl ether amines with peaked distribution